Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2014
10/07/2014US8853358 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/07/2014US8853357 High purity lipopeptides
10/07/2014US8853356 Use of pentagastrin to inhibit gastric acid secretion or as a diuretic
10/07/2014US8853355 Diagnosis and risk stratification by determining the marker CT-proADM
10/07/2014US8853353 Membrane type-1 matrix metalloprotein inhibitors and uses thereof
10/07/2014US8853325 Water-soluble polymer alkanals
10/07/2014US8853217 Compounds useful as inhibitors of ATR kinase
10/07/2014US8853180 Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides
10/07/2014US8853178 Antisense modulation of PTP1B expression
10/07/2014US8853168 Compositions for the reversible thioesterification of signaling proteins and methods of using same
10/07/2014US8853166 Neurotrophic factor MANF and uses thereof
10/07/2014US8853165 Peptide having the ability to regenerate bone tissue and for binding to apatite
10/07/2014US8853164 Oligopeptide improving differentiation of osteoblasts
10/07/2014US8853163 Methods for increasing vascular density and maintaining viability of microvascular endothelial cells using trk receptor ligands
10/07/2014US8853162 Interpenetrating polymer network comprising fibrin
10/07/2014US8853161 Glycopegylation methods and proteins/peptides produced by the methods
10/07/2014US8853160 GLP-1, exendin-4, peptide analogs and uses thereof
10/07/2014US8853159 GLP-1 Fusion Peptides
10/07/2014US8853158 Methods for the treatment of a feeding disorder with onset during neonate development using an agonist of the oxytocin receptor
10/07/2014US8853157 Methods of treating steroid-induced obesity using GLP-1 agonists
10/07/2014US8853156 Treatment for diabetes in patients inappropriate for metformin therapy
10/07/2014US8853155 Insulin derivatives containing additional disulfide bonds
10/07/2014US8853154 Fibronectin based scaffold domain proteins that bind to myostatin
10/07/2014US8853153 Agent for suppressing elevation of blood GIP concentration
10/07/2014US8853151 Pro-drug complexes and related methods of use
10/07/2014US8853150 Chimeric IL-1 receptor type I antagonists
10/07/2014US8853149 Integrin interaction inhibitors for the treatment of cancer
10/07/2014US8853148 Compositions for masking the flavor of nutrients and methods for making same
10/07/2014US8853147 Use of peptide epoxyketones for metastasis suppression
10/07/2014US8853146 Hapten compounds and compositions and uses thereof
10/07/2014US8853131 Modified Stefin A scaffold proteins
10/07/2014US8852927 Microorganisms for imaging and/or treatment of tumors
10/07/2014US8852917 Thuricin CD, an antimicrobial for specifically targeting Clostridium difficile
10/07/2014US8852916 Compositions and methods for therapeutic delivery with microorganisms
10/07/2014US8852899 Methods of making nylon intermediates from glycerol
10/07/2014US8852883 Rapid FRET-based diagnosis of bacterial pathogens
10/07/2014US8852879 Materials and methods for the detection of nitrated fibrinogen
10/07/2014US8852860 Sperm-specific cation channel, CatSper1 and uses therefor
10/07/2014US8852650 Use of BBI/BBIC for treatment of muscular atrophy and degenerative muscle disease
10/07/2014US8852648 Delivery of biologically-active agents using volatile, hydrophobic solvents
10/07/2014US8852645 Self-assembled toroidal-spiral particles and manufacture and uses thereof
10/07/2014US8852614 Hydrogels with network defects enhanced by nanoparticle incorporation
10/07/2014US8852612 Universal carrier for targeting molecules to Gb3 receptor expressing cells
10/07/2014US8852607 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/07/2014US8852605 Vibrio cholerae O139 conjugate vaccines
10/07/2014US8852603 Inhibition of secretion from non-neuronal cells
10/07/2014US8852602 Immunological herpes simplex virus antigens and methods for use thereof
10/07/2014US8852601 Method of stimulating growth and resistance to diseases of aquatic organisms
10/07/2014US8852591 Combination of BLyS and/or APRIL inhibition and immunosuppressants for treatment of autoimmune disease
10/07/2014US8852584 Bactericide having selectivity to cariogenic bacterium, and a method for sterilization of cariogenic bacterium
10/07/2014US8852583 Compositions and methods of using chondroitinase ABCI mutants
10/07/2014US8852582 Compositions comprising glutathione reductase and oxidized glutathione
10/07/2014US8852577 Recombinant proteins of Parapoxvirus ovis and pharmaceutical compositions therefrom
10/07/2014US8852550 Chelator conjugates
10/07/2014US8852151 Swallowable drug delivery device and method of delivery
10/02/2014WO2014160967A2 C. novyi for the treatment of solid tumors in non-human animals
10/02/2014WO2014160956A2 Cartilage-binding fusion proteins
10/02/2014WO2014160883A1 Treating fibrosis and inflammation by inhibiting tl1a
10/02/2014WO2014160768A1 Compositions and methods for preparing a subject for organ or non-organ implantation
10/02/2014WO2014160683A2 Combination therapy for subcutaneous administration of glycopeptide antibiotics
10/02/2014WO2014160508A1 Methods and compositions for treating cancer and inflammatory diseases
10/02/2014WO2014160507A1 Fusion proteins comprising pdgf and vegf binding portions and methods of using thereof
10/02/2014WO2014160497A1 Formulations with reduced oxidation
10/02/2014WO2014160496A1 Skin compositions and uses
10/02/2014WO2014160495A1 Formulations with reduced oxidation
10/02/2014WO2014160463A1 Prefusion rsv f proteins and their use
10/02/2014WO2014160390A1 Therapeutic acid ceramidase compositions and methods of making and using them
10/02/2014WO2014160387A2 Compositions, methods and devices for local drug delivery
10/02/2014WO2014160381A1 Methods and compositions for the prevention and treatment of parasitic disease
10/02/2014WO2014160371A1 Chimeric cytokine formulations for ocular delivery
10/02/2014WO2014160358A1 Use of mir-221 and 222 lowering agents to prevent cardiovascular disease in diabetic subjects
10/02/2014WO2014160318A1 Endogenous vaccine for cancer and infectious diseases
10/02/2014WO2014160281A2 Method of enhancing delivery of therapeutic compounds to the eye
10/02/2014WO2014160272A1 Targeted elimination of factor viii immune cells
10/02/2014WO2014160187A1 Cardiovascular disease treatment and prevention
10/02/2014WO2014160145A2 Immune modulation using peptides and other compositions
10/02/2014WO2014160138A2 Improvement of memory or learning using peptide and other compositions
10/02/2014WO2014160103A2 Treatment of skin, including aging skin, to improve appearance
10/02/2014WO2014160102A1 Brain and neural treatments comprising peptides and other compositions
10/02/2014WO2014160070A2 Methods and systems for treating or preventing cancer
10/02/2014WO2014160069A1 Compositions and methods for affecting mood states
10/02/2014WO2014160049A1 Topical systems and methods for treating sexual dysfunction
10/02/2014WO2014160047A2 Systems and methods for delivery of peptides
10/02/2014WO2014160016A2 Peptide systems and methods for metabolic conditions
10/02/2014WO2014160015A1 Skin tanning using peptides and other compositions
10/02/2014WO2014159990A1 Interferon production using short rna duplexes
10/02/2014WO2014159987A1 Hair treatment systems and methods using peptides and other compositions
10/02/2014WO2014159986A2 Wound healing using topical systems and methods
10/02/2014WO2014159969A1 Stapled and stitched polypeptides and uses thereof
10/02/2014WO2014159941A1 Amyloidosis-inhibiting polypeptides and their use
10/02/2014WO2014159771A1 Prevention of rosacea inflammation
10/02/2014WO2014159679A1 Methods for using lubiprostone to absorb fluid from the subretinal space
10/02/2014WO2014159171A1 Methods of treating lung cancer
10/02/2014WO2014159087A1 Radiolabeled anti-glypican-3 immunoconjugates for immuno-pet imaging of hepatocellular carcinoma
10/02/2014WO2014159080A1 Methods for determining active ingredients of an herbal medicine, sources of and catalytic pathways for production thereof
10/02/2014WO2014158952A1 Hydrochloride salts of an antibiotic compound
10/02/2014WO2014158001A1 Composition comprising at least two influenza a virus-neutralizing-binding molecules
10/02/2014WO2014157485A1 Peptide with anti-aging effect and use thereof
10/02/2014WO2014157156A1 Protein composition and production process therefor
10/02/2014WO2014157153A1 Muscle-atrophy-preventing agent
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 3163